These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 26986127)

  • 1. High Fibroblast Growth Factor 23 Levels Associated With Low Hemoglobin Levels in Patients With Chronic Kidney Disease Stages 3 and 4.
    Tsai MH; Leu JG; Fang YW; Liou HH
    Medicine (Baltimore); 2016 Mar; 95(11):e3049. PubMed ID: 26986127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.
    Pavik I; Jaeger P; Ebner L; Wagner CA; Petzold K; Spichtig D; Poster D; Wüthrich RP; Russmann S; Serra AL
    Nephrol Dial Transplant; 2013 Feb; 28(2):352-9. PubMed ID: 23129826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dialysis vintage and parathyroid hormone level, not fibroblast growth factor-23, determines chronic-phase phosphate wasting after renal transplantation.
    Tomida K; Hamano T; Ichimaru N; Fujii N; Matsui I; Nonomura N; Tsubakihara Y; Rakugi H; Takahara S; Isaka Y
    Bone; 2012 Oct; 51(4):729-36. PubMed ID: 22796419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intact fibroblast growth factor 23 levels predict incident cardiovascular event before but not after the start of dialysis.
    Nakano C; Hamano T; Fujii N; Obi Y; Matsui I; Tomida K; Mikami S; Inoue K; Shimomura A; Nagasawa Y; Okada N; Tsubakihara Y; Rakugi H; Isaka Y
    Bone; 2012 Jun; 50(6):1266-74. PubMed ID: 22425694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of glomerular filtration rate and age on fibroblast growth factor 23 serum levels in pediatric chronic kidney disease.
    Bacchetta J; Dubourg L; Harambat J; Ranchin B; Abou-Jaoude P; Arnaud S; Carlier MC; Richard M; Cochat P
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1741-8. PubMed ID: 20157196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of vitamin D status on the relative increase in fibroblast growth factor 23 and parathyroid hormone in chronic kidney disease.
    Taal MW; Thurston V; McIntyre NJ; Fluck RJ; McIntyre CW
    Kidney Int; 2014 Aug; 86(2):407-13. PubMed ID: 24429404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deviations from the expected relationship between serum FGF23 and other markers in children with CKD: a cross-sectional study.
    Liu D; Alvarez-Elías AC; Wile B; Belostotsky V; Filler G
    BMC Nephrol; 2017 Jun; 18(1):204. PubMed ID: 28659167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum hepcidin-25 levels and anemia in non-dialysis chronic kidney disease patients: a cross-sectional study.
    Uehata T; Tomosugi N; Shoji T; Sakaguchi Y; Suzuki A; Kaneko T; Okada N; Yamamoto R; Nagasawa Y; Kato K; Isaka Y; Rakugi H; Tsubakihara Y
    Nephrol Dial Transplant; 2012 Mar; 27(3):1076-83. PubMed ID: 21799206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum level of fibroblast growth factor 23 in maintenance renal transplant patients.
    Sánchez Fructuoso AI; Maestro ML; Pérez-Flores I; Valero R; Rafael S; Veganzones S; Calvo N; De la Orden V; De la Flor JC; Valga F; Vidaurreta M; Fernández-Pérez C; Barrientos A
    Nephrol Dial Transplant; 2012 Nov; 27(11):4227-35. PubMed ID: 23144073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of fibroblast growth factor 23 (FGF23) in the metabolism of phosphorus and calcium immediately after kidney transplantation.
    Sánchez Fructuoso AI; Maestro ML; Calvo N; De La Orden V; Pérez Flores I; Vidaurreta M; Valero R; Fernández-Pérez C; Barrientos A
    Transplant Proc; 2012 Nov; 44(9):2551-4. PubMed ID: 23146451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Dapagliflozin on Circulating Markers of Phosphate Homeostasis.
    de Jong MA; Petrykiv SI; Laverman GD; van Herwaarden AE; de Zeeuw D; Bakker SJL; Heerspink HJL; de Borst MH
    Clin J Am Soc Nephrol; 2019 Jan; 14(1):66-73. PubMed ID: 30559106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the Renin-Angiotensin system blockade on hemoglobin levels in type 2 diabetic patients with chronic kidney disease.
    Inoue A; Babazono T; Iwamoto Y
    Am J Hypertens; 2008 Mar; 21(3):317-22. PubMed ID: 18202667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating Fibroblast Growth Factor-23 Levels are Associated with an Increased Risk of Anemia Development in Patients with Nondialysis Chronic Kidney Disease.
    Nam KH; Kim H; An SY; Lee M; Cha MU; Park JT; Yoo TH; Lee KB; Kim YH; Sung SA; Lee J; Kang SW; Choi KH; Ahn C; Han SH
    Sci Rep; 2018 May; 8(1):7294. PubMed ID: 29740119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of fibroblast growth factor-23 in chronic kidney disease.
    Westerberg PA; Linde T; Wikström B; Ljunggren O; Stridsberg M; Larsson TE
    Nephrol Dial Transplant; 2007 Nov; 22(11):3202-7. PubMed ID: 17567652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of erythropoietin resistance and fibroblast growth factor 23 in dialysis patients: Results from the Japanese Dialysis Outcomes and Practice Patterns Study.
    Usui T; Zhao J; Fuller DS; Hanafusa N; Hasegawa T; Fujino H; Nomura T; Zee J; Young E; Robinson BM; Nangaku M
    Nephrology (Carlton); 2021 Jan; 26(1):46-53. PubMed ID: 32743932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined use of vitamin D status and FGF23 for risk stratification of renal outcome.
    Nakano C; Hamano T; Fujii N; Matsui I; Tomida K; Mikami S; Inoue K; Obi Y; Okada N; Tsubakihara Y; Isaka Y; Rakugi H
    Clin J Am Soc Nephrol; 2012 May; 7(5):810-9. PubMed ID: 22362065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Administration of Ferric Citrate Hydrate Decreases Circulating FGF23 Levels Independently of Serum Phosphate Levels in Hemodialysis Patients with Iron Deficiency.
    Iguchi A; Kazama JJ; Yamamoto S; Yoshita K; Watanabe Y; Iino N; Narita I
    Nephron; 2015; 131(3):161-6. PubMed ID: 26551233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast Growth Factor 23 and Anemia in the Chronic Renal Insufficiency Cohort Study.
    Mehta R; Cai X; Hodakowski A; Lee J; Leonard M; Ricardo A; Chen J; Hamm L; Sondheimer J; Dobre M; David V; Yang W; Go A; Kusek JW; Feldman H; Wolf M; Isakova T;
    Clin J Am Soc Nephrol; 2017 Nov; 12(11):1795-1803. PubMed ID: 28784656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Phosphate Levels Modify the Impact of FGF23 Levels on Hemoglobin in Chronic Kidney Disease.
    Navarro-González JF; Mora-Fernández C; Diaz-Tocados JM; Bozic M; Bermúdez-López M; Martín M; Valdivielso JM
    Nutrients; 2022 Nov; 14(22):. PubMed ID: 36432528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of indoxyl sulfate with fibroblast growth factor 23 in patients with advanced chronic kidney disease.
    Lin CJ; Pan CF; Chuang CK; Liu HL; Sun FJ; Wang TJ; Chen HH; Wu CJ
    Am J Med Sci; 2014 May; 347(5):370-6. PubMed ID: 24051956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.